With the ever expanding possibilities to build supramotecutar structures, chemists are challenged to mimic nature including the construction of artificial cells or function thereof. Within the field of immunology, effective immunotherapy critically depends on efficient production of antigen-specific cytotoxic T-cells. Herein lies an opportunity for chemists to design and synthesize so-called artificial antigen presenting cells (aAPCs) that can promote T-cell activation and their subsequent expansion. In this review we discuss the current status of aAPC development, also focusing on developments in nanoscience which might improve future designs. As synthetic mimics of natural antigen-presenting cells, aAPCs encompass three basic signals requ...
Contains fulltext : 137111.pdf (publisher's version ) (Open Access)Active anti-can...
Nanosized artificial antigen-presenting cells (aAPCs), synthetic immune cell mimics that aim to acti...
Artificial antigen-presenting cells (aAPCs) have recently gained a lot of attention. They efficientl...
\u3cp\u3eWith the ever expanding possibilities to build supramolecular structures, chemists are chal...
Contains fulltext : 137058.pdf (publisher's version ) (Closed access)With the ever...
Particles engineered to engage and interact with cell surface ligands and to modulate cells can be h...
Adoptive T-cell transfer for cancer therapy relies on both effective ex vivo T-cell expansion and in...
AbstractArtificial antigen presenting cells (aAPCs) are engineered platforms for T cell activation a...
T-cell interactions with antigen-presenting cells (APCs) are involved in nearly every immunological ...
T-cell interactions with antigen-presenting cells (APCs) are involved in nearly every immunological ...
Active anti-cancer immune responses depend on efficient presentation of tumor antigens and co-stimul...
Active anti-cancer immune responses depend on efficient presentation of tumor antigens and co-stimul...
While the beneficial impact of modifying and/or targeting T lymphocytes is becoming increasingly acc...
Artificial Antigen Presenting Cells (aAPC) are synthetic platforms for T cell activation, made by c...
Nanosized artificial antigen-presenting cells (aAPCs), synthetic immune cell mimics that aim to acti...
Contains fulltext : 137111.pdf (publisher's version ) (Open Access)Active anti-can...
Nanosized artificial antigen-presenting cells (aAPCs), synthetic immune cell mimics that aim to acti...
Artificial antigen-presenting cells (aAPCs) have recently gained a lot of attention. They efficientl...
\u3cp\u3eWith the ever expanding possibilities to build supramolecular structures, chemists are chal...
Contains fulltext : 137058.pdf (publisher's version ) (Closed access)With the ever...
Particles engineered to engage and interact with cell surface ligands and to modulate cells can be h...
Adoptive T-cell transfer for cancer therapy relies on both effective ex vivo T-cell expansion and in...
AbstractArtificial antigen presenting cells (aAPCs) are engineered platforms for T cell activation a...
T-cell interactions with antigen-presenting cells (APCs) are involved in nearly every immunological ...
T-cell interactions with antigen-presenting cells (APCs) are involved in nearly every immunological ...
Active anti-cancer immune responses depend on efficient presentation of tumor antigens and co-stimul...
Active anti-cancer immune responses depend on efficient presentation of tumor antigens and co-stimul...
While the beneficial impact of modifying and/or targeting T lymphocytes is becoming increasingly acc...
Artificial Antigen Presenting Cells (aAPC) are synthetic platforms for T cell activation, made by c...
Nanosized artificial antigen-presenting cells (aAPCs), synthetic immune cell mimics that aim to acti...
Contains fulltext : 137111.pdf (publisher's version ) (Open Access)Active anti-can...
Nanosized artificial antigen-presenting cells (aAPCs), synthetic immune cell mimics that aim to acti...
Artificial antigen-presenting cells (aAPCs) have recently gained a lot of attention. They efficientl...